Clinical Trials Browser

Phase 1/2 × Recurrence × ASTX-660 × Clear all

NCT04362007 2026-02-25

A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Phase 1/2 Terminated

8 enrolled 11 charts

Lymphoma, Recurrence